
Redhill Biopharma Ltd.
RDHL institutional ownership changes in Q2 2026: 5 institutions opened or added positions, 2 trimmed or exited. RDHL (Redhill Biopharma Ltd.) is held by 8 institutional investors as of Q2 2026. Top institutional shareholders: Citadel Advisors LLC ($55,196), RhumbLine Advisers ($11,620), Lido Advisors, LLC ($9,303). Institutions were buying, on balance.
Who's Trading
Latest move
Source dates: Price Nov 6, 2026 · Insiders Oct 6, 2026 · Activists Dec 23, 2025 · Congress none
Top Holders
| Insider | Trade | Traded |
|---|---|---|
| Raday Gilead | Sell $1K | |
| Raday Gilead | Sell $1K | |
| Raday Gilead | Sell $2K |
| Filer | Stake | Filed |
|---|---|---|
| YA II PN, Ltd. | 9.9% | |
| Alumni Capital LP | 10.0% |
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about RDHL
Who owns RDHL?
8 institutional investors held RDHL on June 30, 2026, led by Citadel Advisors LLC ($55,196), RhumbLine Advisers ($11,620) and Lido Advisors, LLC ($9,303).
How many hedge funds hold RDHL?
8 institutional investors reported RDHL in their 13F filings for the quarter ended June 30, 2026, $82,767 in all.
Are institutions buying or selling RDHL?
Buying, on balance. In Q2 2026, 5 institutions opened or added to positions in RDHL and 2 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer